TrialPharmacoEconomics1999

A prospective cost-consequence analysis of adding lamivudine to zidovudine-containing antiretroviral treatment regimens for HIV infection in the US.

L Lacey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.